Qaiser Kanza N, Lane James E, Tonelli Adriano R
Department of Internal Medicine, Cleveland Clinic, Cleveland, USA.
Medical Intensive Care, Nursing Institute, Cleveland Clinic, Cleveland, USA.
Pulm Circ. 2020 Sep 16;10(3):2045894020948783. doi: 10.1177/2045894020948783. eCollection 2020 Jul-Sep.
Right heart catheterization is an essential diagnostic modality in the evaluation of pulmonary hypertension. The coronavirus disease 2019 pandemic has resulted in deferral of elective procedures including right heart catheterization. The benefits of proceeding with right heart catheterization, such as further characterization of hemodynamic subtype and severity of pulmonary hypertension, initiation of targeted pulmonary arterial hypertension therapy, as well as further hemodynamic testing, need to be carefully balanced with the risk of potentially exposing both patients and health care personnel to coronavirus disease 2019 infection. This review article aims to provide best clinical practices for safely performing right heart catheterization in pulmonary hypertension patients during the coronavirus disease 2019 pandemic.
右心导管检查是评估肺动脉高压的重要诊断方法。2019冠状病毒病大流行导致包括右心导管检查在内的择期手术推迟。进行右心导管检查的益处，如进一步明确肺动脉高压的血流动力学亚型和严重程度、启动针对性的肺动脉高压治疗以及进一步的血流动力学检测，需要与患者和医护人员可能暴露于2019冠状病毒病感染的风险进行仔细权衡。这篇综述文章旨在提供在2019冠状病毒病大流行期间安全地为肺动脉高压患者进行右心导管检查的最佳临床实践。
